Incidence and Risk Factors of In-Stent Restenosis for Symptomatic Intracranial Atherosclerotic Stenosis: A Systematic Review and Meta-Analysis

References

1. 1.↵
   1. Sacco RL,
   2. Kargman DE,
   3. Gu Q, et al

   . Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction: the Northern Manhattan Stroke Study. Stroke 1995;26:14–20 doi:10.1161/01.str.26.1.14 pmid:7839388

   Abstract/FREE Full Text
2. 2.↵
   1. Wityk RJ,
   2. Lehman D,
   3. Klag M, et al

   . Race and sex differences in the distribution of cerebral atherosclerosis. Stroke 1996;27:1974–80 doi:10.1161/01.str.27.11.1974 pmid:8898801

   Abstract/FREE Full Text
3. 3.↵
   1. Chimowitz MI,
   2. Lynn MJ,
   3. Derdeyn CP, et al

   ; SAMMPRIS Trial Investigators. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med 2011;365:993–1003 doi:10.1056/NEJMoa1105335 pmid:21899409

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Zaidat OO,
   2. Fitzsimmons BF,
   3. Woodward BK, et al

   ; VISSIT Trial Investigators. Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial. JAMA 2015;313:1240–48 doi:10.1001/jama.2015.1693 pmid:25803346

   CrossRefPubMed
5. 5.↵
   1. Chimowitz MI,
   2. Lynn MJ,
   3. Howlett-Smith H, et al

   ; Warfarin-Aspirin Symptomatic Intracranial Disease Trial Investigators. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005;352:1305–16 doi:10.1056/NEJMoa043033 pmid:15800226

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Alexander MJ,
   2. Zauner A,
   3. Chaloupka JC, et al

   ; WEAVE Trial Sites and Interventionalists. WEAVE trial: final results in 152 on-label patients. Stroke 2019;50:889–94 doi:10.1161/STROKEAHA.118.023996 pmid:31125298

   CrossRefPubMed
7. 7.↵
   1. Jin M,
   2. Fu X,
   3. Wei Y, et al

   . Higher risk of recurrent ischemic events in patients with intracranial in-stent restenosis. Stroke 2013;44:2990–94 doi:10.1161/STROKEAHA.113.001824 pmid:23963335

   Abstract/FREE Full Text
8. 8.↵
   1. Levy EI,
   2. Turk AS,
   3. Albuquerque FC, et al

   . Wingspan in-stent restenosis and thrombosis: incidence, clinical presentation, and management. Neurosurgery 2007;61:644–50; discussion 50–51 doi:10.1227/01.NEU.0000290914.24976.83 pmid:17881980

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Alurkar A,
   2. Karanam LS,
   3. Oak S, et al

   . Role of balloon-expandable stents in intracranial atherosclerotic disease in a series of 182 patients. Stroke 2013;44:2000–03 doi:10.1161/STROKEAHA.113.001446 pmid:23696549

   Abstract/FREE Full Text
10. 10.↵
    1. Li J,
    2. Zhao ZW,
    3. Gao GD, et al

    . Wingspan stent for high-grade symptomatic vertebrobasilar artery atherosclerotic stenosis. Cardiovasc Intervent Radiol 2012;35:268–78 doi:10.1007/s00270-011-0163-5 pmid:21516376

    CrossRefPubMed
11. 11.↵
    1. Zhang L,
    2. Huang Q,
    3. Zhang Y, et al

    . Wingspan stents for the treatment of symptomatic atherosclerotic stenosis in small intracranial vessels: safety and efficacy evaluation. AJNR Am J Neuroradiol 2012;33:343–47 doi:10.3174/ajnr.A2772 pmid:22173759

    Abstract/FREE Full Text
12. 12.↵
    1. Moher D,
    2. Liberati A,
    3. Tetzlaff J, et al

    ; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 2009;62:1006–12 doi:10.1016/j.jclinepi.2009.06.005 pmid:19631508

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Slim K,
    2. Nini E,
    3. Forestier D, et al

    . Methodological Index for Non-Randomized Studies (MINORS): development and validation of a new instrument. ANZ J Surg 2003;73:712–76 doi:10.1046/j.1445-2197.2003.02748.x pmid:12956787

    CrossRefPubMedWeb of Science
14. 14.↵
    1. Wells GA,
    2. Shea B,
    3. O’Connell D, et al

    . The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonradomized studies in meta-analyses. 2014. Ottawal Hospital Research Institute. https://www.researchgate.net/publication/288802810_The_Newcastle-Ottawa_Scale_NOS_for_Assessing_The_Quality_of_Nonrandomised_Studies_in_Meta-analyses. Assessed November 19, 2019
15. 15.↵
    1. Bai WX,
    2. Gao BL,
    3. Li TX, et al

    . Wingspan stenting can effectively prevent long-term strokes for patients with severe symptomatic atherosclerotic basilar stenosis. Interv Neuroradiol 2016;22:318–24 doi:10.1177/1591019915623797 pmid:26823331

    CrossRefPubMed
16. 16.
    1. Bose A,
    2. Hartmann M,
    3. Henkes H, et al

    . A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: the Wingspan study. Stroke 2007;38:1531–57 doi:10.1161/STROKEAHA.106.477711 pmid:1739586

    Abstract/FREE Full Text
17. 17.
    1. Du Z,
    2. Mang J,
    3. Yu S, et al

    . Weighing in on the off-label use: initial experience of Neuroform EZ stenting for intracranial arterial stenosis in 45 patients. Front Neurol 2018;9:852 doi:10.3389/fneur.2018.00852 pmid:30364175

    CrossRefPubMed
18. 18.
    1. Durst CR,
    2. Geraghty SR,
    3. Southerland AM, et al

    . Stenting of symptomatic intracranial stenosis using balloon mounted coronary stents: a single center experience. J Neurointerv Surg 2015;7:245–49 doi:10.1136/neurintsurg-2014-011185 pmid:24646693

    Abstract/FREE Full Text
19. 19.
    1. Feng Z,
    2. Duan G,
    3. Zhang P, et al

    . Enterprise stent for the treatment of symptomatic intracranial atherosclerotic stenosis: an initial experience of 44 patients. BMC Neurol 2015;15:187 doi:10.1186/s12883-015-0443-9 pmid:26449986

    CrossRefPubMed
20. 20.
    1. Fiorella D,
    2. Chow MM,
    3. Anderson M, et al

    . A 7-year experience with balloon-mounted coronary stents for the treatment of symptomatic vertebrobasilar intracranial atheromatous disease. Neurosurgery 2007;61:236–42; discussion 42–43 doi:10.1227/01.NEU.0000255521.42579.31 pmid:17762735

    CrossRefPubMedWeb of Science
21. 21.
    1. Freitas JM,
    2. Zenteno M,
    3. Aburto-Murrieta Y, et al

    . Intracranial arterial stenting for symptomatic stenoses: a Latin American experience. Surg Neurol 2007;68:378–86 doi:10.1016/j.surneu.2006.11.062 pmid:17905061

    CrossRefPubMedWeb of Science
22. 22.
    1. Gandini R,
    2. Chiaravalloti A,
    3. Pampana E, et al

    . Intracranial atheromatous disease treatment with the Wingspan stent system: evaluation of clinical, procedural outcome and restenosis rate in a single-center series of 21 consecutive patients with acute and mid-term results. Clin Neurol Neurosurg 2013;115:741–47 doi:10.1016/j.clineuro.2012.08.037 pmid:22989778

    CrossRefPubMed
23. 23.
    1. Guo XB,
    2. Ma N,
    3. Hu XB, et al

    . Wingspan stent for symptomatic M1 stenosis of middle cerebral artery. Eur J Radiol 2011;80:e356–60 doi:10.1016/j.ejrad.2010.11.029 pmid:21163599

    CrossRefPubMed
24. 24.
    1. He Y,
    2. Wang Z,
    3. Li T, et al

    . Preliminary findings of recanalization and stenting for symptomatic vertebrobasilar artery occlusion lasting more than 24h: a retrospective analysis of 21 cases. Eur J Radiol 2013;82:1481–86 doi:10.1016/j.ejrad.2013.04.021 pmid:23706495

    CrossRefPubMed
25. 25.
    1. Jiang WJ,
    2. Cheng-Ching E,
    3. Abou-Chebl A, et al

    . Multicenter analysis of stenting in symptomatic intracranial atherosclerosis. Neurosurgery 2012;70:25–30; discussion 31 doi:10.1227/NEU.0b013e31822d274d

    CrossRefPubMedWeb of Science
26. 26.
    1. Jiang WJ,
    2. Xu XT,
    3. Du B, et al

    . Comparison of elective stenting of severe vs moderate intracranial atherosclerotic stenosis. Neurology 2007;68:420–26 doi:10.1212/01.wnl.0000252939.60764.8e pmid:17283316

    Abstract/FREE Full Text
27. 27.
    1. Jiang WJ,
    2. Yu W,
    3. Du B, et al

    . Outcome of patients with ≥70% symptomatic intracranial stenosis after Wingspan stenting. Stroke 2011;42:1971–75 doi:10.1161/STROKEAHA.110.595926 pmid:21636814

    Abstract/FREE Full Text
28. 28.
    1. Kim KS,
    2. Hwang DH,
    3. Ko YH, et al

    . Usefulness of stent implantation for treatment of intracranial atherosclerotic stenoses. Neurointervention 2012;7:27–33 doi:10.5469/neuroint.2012.7.1.27 pmid:22454782

    CrossRefPubMed
29. 29.
    1. Lee KY,
    2. Chen DY,
    3. Hsu HL, et al

    . Undersized angioplasty and stenting of symptomatic intracranial tight stenosis with Enterprise: evaluation of clinical and vascular outcome. Interv Neuroradiol 2016;22:187–95 doi:10.1177/1591019915609165 pmid:26542728

    CrossRefPubMed
30. 30.
    1. Li G,
    2. Wang N,
    3. Li X, et al

    . Balloon-mounted versus self-expanding stent outcomes in symptomatic middle cerebral artery stenosis combined with poor collaterals in China: a multicenter registry study. World Neurosurg 2019 Jan 16 [Epub ahead of Print] doi:10.1016/j.wneu.2018.12.189 pmid:30659967

    CrossRefPubMed
31. 31.
    1. Li TX,
    2. Gao BL,
    3. Cai DY, et al

    . Wingspan stenting for severe symptomatic intracranial atherosclerotic stenosis in 433 patients treated at a single medical center. PLoS One 2015;10:e0139377 doi:10.1371/journal.pone.0139377 pmid:26422692

    CrossRefPubMed
32. 32.
    1. Li Y,
    2. Tang L,
    3. Qi D, et al

    . Correlation between high perfusion syndrome and stent restenosis after stent implantation. Exp Ther Med 2016;12:3675–79 doi:10.3892/etm.2016.3813 pmid:28101162

    CrossRefPubMed
33. 33.
    1. Lylyk P,
    2. Vila JF,
    3. Miranda C, et al

    . Endovascular reconstruction by means of stent placement in symptomatic intracranial atherosclerotic stenosis. Neurol Res 2005;27(Suppl 1):S84–88 doi:10.1179/016164105X35495 pmid:16197831

    CrossRefPubMedWeb of Science
34. 34.
    1. Maier IL,
    2. Karch A,
    3. Lipke C, et al

    . Transluminal angioplasty and stenting versus conservative treatment in patients with symptomatic basilar artery stenosis: perspective for future clinical trials. Clin Neuroradiol 2018;28:33–38 doi:10.1007/s00062-016-0528-x pmid:27506672

    CrossRefPubMed
35. 35.
    1. Miao ZR,
    2. Feng L,
    3. Li S, et al

    . Treatment of symptomatic middle cerebral artery stenosis with balloon-mounted stents: long-term follow-up at a single center. Neurosurgery 2009;64:79–84 doi:10.1227/01.NEU.0000335648.31874.37 pmid:19050657

    CrossRefPubMedWeb of Science
36. 36.↵
    1. Park S,
    2. Kim JH,
    3. Kwak JK, et al

    . Intracranial stenting for severe symptomatic stenosis: self-expandable versus balloon-expandable stents. Interv Neuroradiol 2013;19:276–82 doi:10.1177/159101991301900303 pmid:24070075

    CrossRefPubMed
37. 37.
    1. Park SC,
    2. Cho SH,
    3. Kim MK, et al

    . Long-term outcome of angioplasty using a Wingspan stent, post-stent balloon dilation and aggressive restenosis management for intracranial arterial stenosis. Clin Neuroradiol 2020;30:159–69 doi:10.1007/s00062-019-00793-1 pmid:31123775

    CrossRefPubMed
38. 38.
    1. Qureshi AI,
    2. Hussein HM,
    3. El-Gengaihy A, et al

    . Concurrent comparison of outcomes of primary angioplasty and of stent placement in high-risk patients with symptomatic intracranial stenosis. Neurosurgery 2008;62:1053–60; discussion 60–62 doi:10.1227/01.neu.0000325867.06764.3a pmid:18580803

    CrossRefPubMedWeb of Science
39. 39.
    1. Salik AE,
    2. Selcuk HH,
    3. Zalov H, et al

    . Medium-term results of undersized angioplasty and stenting for symptomatic high-grade intracranial atherosclerotic stenosis with Enterprise. Interv Neuroradiol 2019;25:484–90 doi:10.1177/1591019919832244 pmid:30991867

    CrossRefPubMed
40. 40.
    1. Samaniego EA,
    2. Tari-Capone F,
    3. Linfante I, et al

    . Wingspan experience in the treatment of symptomatic intracranial atherosclerotic disease after antithrombotic failure. J Neurointerv Surg 2013;5:302–05 doi:10.1136/neurintsurg-2012-010321 pmid:22544819

    Abstract/FREE Full Text
41. 41.
    1. Shin YS,
    2. Kim BM,
    3. Suh SH, et al

    . Wingspan stenting for intracranial atherosclerotic stenosis: clinical outcomes and risk factors for in-stent restenosis. Neurosurgery 2013;72:596–604; discussion 604 doi:10.1227/NEU.0b013e3182846e09 pmid:23277374

    CrossRefPubMed
42. 42.
    1. Suh DC,
    2. Kim JK,
    3. Choi JW, et al

    . Intracranial stenting of severe symptomatic intracranial stenosis: results of 100 consecutive patients. AJNR Am J Neuroradiol 2008;29:781–85 doi:10.3174/ajnr.A0922

    Abstract/FREE Full Text
43. 43.
    1. Tang CW,
    2. Chang FC,
    3. Chern CM, et al

    . Stenting versus medical treatment for severe symptomatic intracranial stenosis. AJNR Am J Neuroradiol 2011;32:911–16 doi:10.3174/ajnr.A2409 pmid:21393399

    Abstract/FREE Full Text
44. 44.
    1. Wang X,
    2. Wang Z,
    3. Wang C, et al

    . Application of the Enterprise stent in atherosclerotic intracranial arterial stenosis: a series of 60 cases. Turk Neurosurg 2016;26:69–76 doi:10.5137/1019-5149.JTN.13350-14.1 pmid:26768871

    CrossRefPubMed
45. 45.↵
    1. Wang ZL,
    2. Gao BL,
    3. Li TX, et al

    . Symptomatic intracranial vertebral artery atherosclerotic stenosis (≥70%) with concurrent contralateral vertebral atherosclerotic diseases in 88 patients treated with the intracranial stenting. Eur J Radiol 2015;84:1801–04 doi:10.1016/j.ejrad.2015.05.033

    CrossRef
46. 46.
    1. Wang ZL,
    2. Gao BL,
    3. Li TX, et al

    . Outcomes of middle cerebral artery angioplasty and stenting with Wingspan at a high-volume center. Neuroradiology 2016;58:161–69 doi:10.1007/s00234-015-1611-8

    CrossRefPubMed
47. 47.
    1. Wolfe TJ,
    2. Fitzsimmons BF,
    3. Hussain SI, et al

    . Long term clinical and angiographic outcomes with the Wingspan stent for treatment of symptomatic 50-99% intracranial atherosclerosis: single center experience in 51 cases. J Neurointerv Surg 2009;1:40–43 doi:10.1136/jnis.2009.000331 pmid:21994104

    Abstract/FREE Full Text
48. 48.
    1. Yu J,
    2. Wang L,
    3. Deng JP, et al

    . Treatment of symptomatic intracranial atherosclerotic stenosis with a normal-sized Gateway TM balloon and Wingspan TM stent. J Int Med Res 2010;38:1968–74 doi:10.1177/147323001003800610 pmid:21227000

    CrossRefPubMed
49. 49.
    1. Yu SC,
    2. Leung TW,
    3. Lee KT, et al

    . Angioplasty and stenting of atherosclerotic middle cerebral arteries with Wingspan: evaluation of clinical outcome, restenosis, and procedure outcome. AJNR Am J Neuroradiol 2011;32:753–58 doi:10.3174/ajnr.A2363 pmid:21436335

    Abstract/FREE Full Text
50. 50.
    1. Yu SC,
    2. Leung TW,
    3. Lee KT, et al

    . Angioplasty and stenting of intracranial atherosclerosis with the Wingspan system: 1-year clinical and radiological outcome in a single Asian center. J Neurointerv Surg 2014;6:96–102 doi:10.1136/neurintsurg-2012-010608 pmid:23512176

    Abstract/FREE Full Text
51. 51.↵
    1. Yue X,
    2. Xi G,
    3. Lu T, et al

    . Influence of residual stenosis on clinical outcome and restenosis after middle cerebral artery stenting. Cardiovasc Intervent Radiology 2011;34:744–50 doi:10.1007/s00270-010-9989-5 pmid:20927521

    CrossRefPubMed
52. 52.↵
    1. Zhang L,
    2. Huang Q,
    3. Zhang Y, et al

    . A single-center study of Wingspan stents for symptomatic atherosclerotic stenosis of the middle cerebral artery. J Clin Neurosci 2013;20:362–66 doi:10.1016/j.jocn.2012.03.033 pmid:23228656

    CrossRefPubMed
53. 53.
    1. Zhang Y,
    2. Rajah GB,
    3. Liu P, et al

    . Balloon-mounted versus self-expanding stents for symptomatic intracranial vertebrobasilar artery stenosis combined with poor collaterals. Neurol Res 2019;41:704–13 doi:10.1080/01616412.2019.1610837 pmid:31030623

    CrossRefPubMed
54. 54.
    1. Zhang Y,
    2. Sun Y,
    3. Li X, et al

    . Early versus delayed stenting for intracranial atherosclerotic artery stenosis with ischemic stroke. J Neurointerv Surg 2020;12:274–78 doi:10.1136/neurintsurg-2019-015035 pmid:31285375

    Abstract/FREE Full Text
55. 55.
    1. Zhou Y,
    2. Hua Y,
    3. Jia L, et al

    . Evaluation of interventional therapy for patients with intracranial vertebral artery stenosis by transcranial color-coded sonography. Ultrasound Med Biol 2016;42:44–50 doi:10.1016/j.ultrasmedbio.2015.08.006 pmid:26410007

    CrossRefPubMed
56. 56.
    1. Zhu SG,
    2. Zhang RL,
    3. Liu WH, et al

    . Predictive factors for in-stent restenosis after balloon-mounted stent placement for symptomatic intracranial atherosclerosis. Eur J Vasc Endovasc Surg 2010;40:499–506 doi:10.1016/j.ejvs.2010.05.007 pmid:20554461

    CrossRefPubMed
57. 57.
    1. Zi W,
    2. Gong Z,
    3. Shuai J

    . Novel approaches in evaluating and predicting the potential benefit of middle cerebral artery angioplasty and stenting. J Neuroimaging 2015;25:620–25 doi:10.1111/jon.12176

    CrossRef
58. 58.↵
    1. Turk AS,
    2. Levy EI,
    3. Albuquerque FC, et al

    . Influence of patient age and stenosis location on Wingspan in-stent restenosis. AJNR Am J Neuroradiol 2008;29:23–27 doi:10.3174/ajnr.A0869 pmid:7989366

    Abstract/FREE Full Text
59. 59.↵
    1. Duan G,
    2. Feng Z,
    3. Zhang L, et al

    . Solitaire stents for the treatment of complex symptomatic intracranial stenosis after antithrombotic failure: safety and efficacy evaluation. J Neurointerv Surg 2016;8:680–84 doi:10.1136/neurintsurg-2015-011734 pmid:26041096

    Abstract/FREE Full Text
60. 60.↵
    1. Derdeyn CP,
    2. Fiorella D,
    3. Lynn MJ, et al

    ; SAMMPRIS Investigators. Nonprocedural symptomatic infarction and in-stent restenosis after intracranial angioplasty and stenting in the SAMMPRIS Trial (Stenting and Aggressive Medical Management for the Prevention of Recurrent Stroke in Intracranial Stenosis). Stroke 2017;48:1501–06 doi:10.1161/STROKEAHA.116.014537 pmid:28455321

    Abstract/FREE Full Text
61. 61.↵
    1. Alenghat FJ

    . The prevalence of atherosclerosis in those with inflammatory connective tissue disease by race, age, and traditional risk factors. Sci Rep 2016;6:20303 doi:10.1038/srep20303 pmid:26842423

    CrossRefPubMed
62. 62.↵
    1. Yue X,
    2. Yin Q,
    3. Xi G, et al

    . Comparison of BMSs with SES for symptomatic intracranial disease of the middle cerebral artery stenosis. Cardiovasc Intervent Radiol 2011;34:54–60 doi:10.1007/s00270-010-9885-z pmid:20458585

    CrossRefPubMed
63. 63.↵
    1. Gröschel K,
    2. Schnaudigel S,
    3. Pilgram SM, et al

    . A systematic review on outcome after stenting for intracranial atherosclerosis. Stroke 2009;40:e340–47 doi:10.1161/STROKEAHA.108.532713 pmid:19182081

    Abstract/FREE Full Text